Warwick G L, Geddes C G, Boulton-Jones J M
Renal Unit, Royal Infirmary, Glasgow, UK.
Q J Med. 1994 Apr;87(4):223-9.
Twenty-one patients with membranous nephropathy, heavy proteinuria and progressive renal failure were treated with alternating monthly cycles of corticosteroids and chlorambucil for six months. Four patients received repeat courses. After a median period of follow-up of 39 months, three patients had died, six were receiving renal replacement therapy or had serum creatinine > 500 mumol/l, and one had progressive renal failure. Eleven patients had either stable or improved renal function, as judged by serum creatinine concentration. Of these eleven, four patients were in partial remission (daily protein excretion 0.2-2.0 g), and two were in complete remission. There was a tendency for those who received intravenous methylprednisolone to have a more favourable outcome. There was a high incidence of side-effects, with significant complications related to drug therapy observed in > 50% of subjects. Although individual patients appeared to respond well, sometimes dramatically, these results are less encouraging than other reports. We would urge caution in the use of this form of therapy, particularly in older patients who may have occult neoplasms, impaired glucose intolerance or pre-existing cardiac disease.
21例膜性肾病伴大量蛋白尿和进行性肾衰竭患者接受了皮质类固醇和苯丁酸氮芥交替治疗,每月为一个周期,共治疗6个月。4例患者接受了重复疗程。在中位随访期39个月后,3例患者死亡,6例正在接受肾脏替代治疗或血清肌酐>500μmol/L,1例出现进行性肾衰竭。根据血清肌酐浓度判断,11例患者肾功能稳定或改善。在这11例患者中,4例部分缓解(每日蛋白尿排泄量0.2 - 2.0g),2例完全缓解。接受静脉注射甲泼尼龙的患者预后似乎更好。副作用发生率较高,超过50%的受试者出现了与药物治疗相关的严重并发症。尽管个别患者反应良好,有时甚至非常显著,但这些结果并不比其他报告更令人鼓舞。我们强烈建议谨慎使用这种治疗方式,尤其是在可能患有隐匿性肿瘤、糖耐量受损或已有心脏病的老年患者中。